Blockade of PAI-1 eliminates leukemic stem cells
Project/Area Number |
15H04301
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Tumor biology
|
Research Institution | Tokai University |
Principal Investigator |
|
Co-Investigator(Renkei-kenkyūsha) |
ANDO Kiyoshi 東海大学, 医学部, 教授 (70176014)
MIYATA Toshio 東北大学, 大学院・医学系研究科, 教授 (10222332)
IBRAHIM Abd Aziz 東海大学, 医学部, 特定研究員(PD) (50738789)
|
Project Period (FY) |
2015-04-01 – 2018-03-31
|
Project Status |
Completed (Fiscal Year 2017)
|
Budget Amount *help |
¥16,770,000 (Direct Cost: ¥12,900,000、Indirect Cost: ¥3,870,000)
Fiscal Year 2017: ¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2016: ¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2015: ¥6,370,000 (Direct Cost: ¥4,900,000、Indirect Cost: ¥1,470,000)
|
Keywords | 白血病 / 幹細胞 / ニッチ / 分子標的薬 / TGF-beta / 白血病幹細胞 / PAI-1 / TGF-b / がん幹細胞 / 薬剤耐性 / 繊維素溶解系 / 治療抵抗性 / 低分子化合物 / MT1-MMP |
Outline of Final Research Achievements |
We found that the expression of TGF-b-iPAI-1 signaling was selectively augmented in CML stem cells. CML cells expressing higher levels of iPAI-1 were resistance to imatinib treatment, indicating the iPAI-1 protects CML cells from TKI treatment. Combined treatment of imatinib plus PAI-1 inhibitor significantly decreased the persistent CML cells in the BM, reduced spleen size, and prolonged survival of CML-bearing mice. Importantly, blockade of PAI-1 activity in combination with TKI effectively eliminated CML stem cells in the BM, which resulted in losing their ability to initiate CML disease in the serial transplanted recipients. The effect of PAI-1 inhibitor to enhance the therapeutic effect of TKI was completely canceled by the administration of neutralizing antibody specific for MT1-MMP. Our findings provide evidence that blockade of PAI-1 activity could be a novel therapeutic approach for CML patients.
|
Report
(4 results)
Research Products
(12 results)
-
-
-
-
-
-
-
[Journal Article] Common marmoset CD117-positive hematopoietic cells possess multipotency2015
Author(s)
Shimada S, Nunomura S, Mori S, Suemizu H, Itoh T, Takabayashi S, Okada Y, Yahata T, Shiina T, Katoh H, Suzuki R, Tani K, Ando K, Yagita H, Habu S, Sasaki E, Kametani Y.
-
Journal Title
Int Immune
Volume: 27
Issue: 11
Pages: 567-577
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
-
-
-